Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01261338 · ClinicalTrials.gov registry record · Early Phase 1
Intervention to Reduce Body Burdens of PCBs in Residents of Anniston, Alabama
A Early Phase 1 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT01261338 is a Early Phase 1 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 28 participants.
The verdict
NCT01261338, a Early Phase 1 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
Because of industrial pollution, a large number of people in Anniston, Alabama, have elevated body burdens of the class of compounds known as polychlorinated biphenyls (PCBs). There is evidence that these compounds are associated with risks to health including diabetes. There is also evidence that the consumption of a non-absorbable dietary fat can reduce the level of compounds like PCBs. This clinical trial will test the hypothesis that a non-absorbable dietary fat can reduce the levels of PCBs in subjects in Anniston.
Interventions
- DRUG olestra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01261338
The ClinicalTrials.gov registry entry for NCT01261338 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which olestra is the first listed.
NCT01261338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01261338 about?
NCT01261338 is a clinical study titled "Intervention to Reduce Body Burdens of PCBs in Residents of Anniston, Alabama". Because of industrial pollution, a large number of people in Anniston, Alabama, have elevated body burdens of the class of compounds known as polychlorinated biphenyls (PCBs). There is evidence that these compounds are associated with risks to health including diabetes. There is also evidence that t...
What is the current status of trial NCT01261338?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2010-12. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01261338?
The interventions under investigation include: olestra (DRUG).
Who is sponsoring clinical trial NCT01261338?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.